logo
Plus   Neg
Share
Email

Fresnillo Sees FY19 More Challenging Than FY18; Says Confident In Long-term View

Mining company Fresnillo plc (FRES.L), in its Annual General Meeting Statement on Tuesday, said that it expects 2019 to be a more challenging year than 2018.

Internal conditions in the long-term remain sound, and the company maintains confidence in Mexico. The company said it will keep investing in the projects under exploration.

Regarding 2018, the company said the year was more challenging for the firm. It recorded strong silver and gold production, but were disappointed not to meet long-term silver target of 65 Moz. Despite a more challenging operating performance, the company maintained a very strong financial position.

Further, the company said it remains very confident in the long-term outlook, based on its track record and proven consistent conservative strategy.

During the 10 years of being listed in the London Stock Exchange, the company said it recorded an 80% increase in silver production and a 230% increase in attributable gold production. The company has also paid over $2.8 billion in dividends.

The Board has recommended a final dividend of 16.7 US cents per Ordinary Share, bringing the total amount paid for the year to $201.9 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Just Egg, a plant-based egg alternative, will be available in 2,100 stores owned by grocery chain Kroger Co. later this month. The product launch comes as plant-based meat and egg alternatives gain traction in the country. Just Egg, a product of California-based food technology company Just Inc., will be available at Kroger-owned stores, including Kroger, Fred Meyer and Ralphs. Boeing has delivered the first 787-10 Dreamliner to Vietnam Airlines, the flag carrier of Vietnam, as part of the eight 787-10 Dreamliner airplanes to be delivered on lease through Air Lease. Vietnam Airlines said the 787-10 Dreamliner, claimed by Boeing to be the most fuel-efficient twin-aisle airplane in the industry, will help it raise the customer experience on the Hanoi to Ho Chi Minh route. The U.S. Food and Drug Administration or FDA announced on its website that pharma major Pfizer, Inc. issued recall of two lots of tablets meant to treat acute migraine in adults for concerns over bacteria infection. The pharma company is recalling two lots of Relpax (eletriptan hydrobromide) 40 mg tablets for potential presence of Genus Pseudomonas and Burkholderia bacteria.
Follow RTT